Compare drug alternatives
Glyxambi® Alternatives
Glyxambi®(empagliflozin / linagliptin) | Steglujan®(ertugliflozin / sitagliptin) |
---|---|
Prescription Only | Prescription Only |
Dosage & Administration | |
Administration | |
Dosing | |
Latin Shorthand | |
Financial Assistance | |
Out-Of-Pocket Costs With Copay Card | |
$10. Learn more. | $0. Learn more. |
Annual Cap | |
$175 per month. Learn more. | $583 per fill . Learn more. |
Assistance Expiration | |
12 uses. Learn more. | |
Generics | |
No lower-cost generic available | No lower-cost generic available |
Physician Advisory | |
Adverse Reactions | |
Most common adverse reactions (5% or greater incidence) were urinary tract
infections, nasopharyngitis, and upper respiratory tract infections.. Learn more. | Most common adverse reactions associated with ertugliflozin
(incidence ≥5%): female genital mycotic infections.
Most common adverse reactions associated with sitagliptin
(incidence ≥5%): upper respiratory tract infection, nasopharyngitis
and headache. In the add-on to sulfonylurea and add-on to insulin
studies, hypoglycemia was also more commonly reported in patients
treated with sitagliptin compared to placebo.. Learn more. |
Mechanism of Actions (MoA) | |
SGLT2 Inhibitors. Learn more. | SGLT2 Inhibitors. Learn more. |
Special Populations | |
Popular Alternatives
- Glyxambi® vs Victoza®
- Glyxambi® vs Trulicity®
- Glyxambi® vs Xultophy®
- Glyxambi® vs Soliqua®
- Glyxambi® vs Ozempic®
- Glyxambi® vs Rybelsus®
- Glyxambi® vs Mounjaro®
- Glyxambi® vs Bydureon®
- Glyxambi® vs Invokamet®
- Glyxambi® vs Invokamet®
- Glyxambi® vs Invokana®
- Glyxambi® vs Farxiga®
- Glyxambi® vs Jardiance®
- Glyxambi® vs Synjardy®
- Glyxambi® vs Trijardy XR®
- Glyxambi® vs Segluromet®
- Glyxambi® vs Steglatro®
- Glyxambi® vs Inpefa®